LeMaitre Vascular
LMAT
$63.26
Share price
1.02%
Change (1 day)
20.02%
Change (1 year)
Categories
LeMaitre Vascular (LMAT) - Total debt
Total debt on the balance sheet as of December 2023 : $19.09 M
According to LeMaitre Vascular's latest financial reports the company's total debt is $19.09 M. A company’s total debt is the sum of all current and non-current debts.
LeMaitre Vascular - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $19.09 M | 15.06% |
| 2022-12-31 | $16.59 M | 4.14% |
| 2021-12-31 | $15.93 M | -70.91% |
| 2020-12-31 | $54.77 M | 248.63% |
| 2019-12-31 | $15.71 M | |
| 2018-12-31 | $N/A | |
| 2009-12-31 | $0.18 M | 141.03% |
| 2008-12-31 | $0.07 M | -74.34% |
| 2007-12-31 | $0.3 M | 850% |
| 2006-12-31 | $0.03 M | -98.32% |
| 2005-12-31 | $1.9 M | 18.42% |
| 2004-12-31 | $1.61 M | |
| 2002-12-31 | $0.93 M | 39.1% |
| 2001-12-31 | $0.67 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $14.36 B | 75,123.88% | 🇺🇸 USA |
 Boston Scientific BSX | $9.49 B | 49,609.35% | 🇺🇸 USA |
 Edwards Lifesciences EW | $0.69 B | 3,539.17% | 🇺🇸 USA |
 Teleflex TFX | $1.92 B | 9,988.35% | 🇺🇸 USA |
 AngioDynamics ANGO | $4.72 M | -75.23% | 🇺🇸 USA |
 Cardiovascular Systems CSII | $20.11 M | 5.35% | 🇺🇸 USA |